| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143242 | Lung Cancer | 2008 | 7 Pages |
Abstract
Three out of four patients preferred oral vinorelbine. Clinical outcomes were comparable to other combination chemotherapy regimens for NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lars Henrik Jensen, Kell Osterlind, Carsten Rytter,